Stocktoria
Cell Source, Inc. CLCS
OTC · stock · Pharmaceutical Preparations · website · IPO 2014-01-14
Cell Source, Inc. statistics & valuation
Market cap$52.8M
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on assets | -1575.1% | -2726.4% | -1260.9% | -1744.1% | -1008.1% | -3899.1% | -3218.4% | -579.8% | -458.4% | -1165.6% |
| Return on equity | 24.3% | 34.1% | 40.9% | 55.7% | 57.4% | 77.9% | 43.0% | 67.6% | 15.5% | 43.5% |
| Debt / equity | — | — | — | — | — | — | — | -0.01× | — | — |
| Current ratio | — | — | — | 0.03 | 0.05 | — | — | 0.10 | 0.03 | 0.04 |
Source: SEC EDGAR filings · CIK 0001569340 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.